Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Bigazzi

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Lipids in Health and Disease|October 22, 2011
Myeloperoxidase modulation by LDL apheresis in familial hypercholesterolemiaMariarita Puntoni, Francesco Sbrana, Federico Bigazzi, et al.
Endocrine|December 24, 2024
Pediatrics cascade screening in inherited dyslipidemias: a lipoprotein apheresis center experienceFrancesco Sbrana, Beatrice Dal Pino, Carmen Corciulo, et al.
Journal of Atherosclerosis and Thrombosis|August 11, 2012
High density lipoprotein cholesterol in coronary artery disease: when higher means laterFrancesco Sbrana, Mariarita Puntoni, Federico Bigazzi, et al.
Circulation|January 5, 2002
Increased plasma C-reactive protein in familial hypoalphalipoproteinemia: a proinflammatory condition?Tiziana Sampietro, Federico Bigazzi, Beatrice Dal Pino, et al.
Journal of Clinical Lipidology|September 1, 2016
Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutationsClaudio Rabacchi, Federico Bigazzi, Mariarita Puntoni, et al.
Journal of Clinical Apheresis|October 19, 2023
Comorbidity in lipoprotein apheresis: Their role in the era of new lipid-lowering therapiesFrancesco Sbrana, Mascia Pianelli, Roberta Luciani, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|October 3, 2009
Low high-density lipoprotein predicts death in patients with mild left ventricular dysfunction regardless of coronary atherosclerosisTiziana Sampietro, Federico Bigazzi, Mariarita Puntoni, et al.
Hormones (Athens, Greece)|November 24, 2023
PCSK9 and leptin plasma levels in anorexia nervosaFederico Bigazzi, Carlotta Francesca De Pasquale, Sandra Maestro, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|September 29, 2023
Major cardiovascular events increase in long-term proprotein convertase subtilisin/kexin type 9 inhibitors therapy: the Tuscany cost-effective studyFrancesco Sbrana, Beatrice Dal Pino, Federico Bigazzi, et al.
Biochemical and Biophysical Research Communications|April 1, 2014
Early senescence in heterozygous ABCA1 mutation skin fibroblasts: a gene dosage effect beyond HDL deficiency?Mariarita Puntoni, Federico Bigazzi, Laura Sabatino, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Lipids in Health and Disease|October 22, 2011
Myeloperoxidase modulation by LDL apheresis in familial hypercholesterolemiaMariarita Puntoni, Francesco Sbrana, Federico Bigazzi, et al.
Endocrine|December 24, 2024
Pediatrics cascade screening in inherited dyslipidemias: a lipoprotein apheresis center experienceFrancesco Sbrana, Beatrice Dal Pino, Carmen Corciulo, et al.
Journal of Atherosclerosis and Thrombosis|August 11, 2012
High density lipoprotein cholesterol in coronary artery disease: when higher means laterFrancesco Sbrana, Mariarita Puntoni, Federico Bigazzi, et al.
Circulation|January 5, 2002
Increased plasma C-reactive protein in familial hypoalphalipoproteinemia: a proinflammatory condition?Tiziana Sampietro, Federico Bigazzi, Beatrice Dal Pino, et al.
Journal of Clinical Lipidology|September 1, 2016
Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutationsClaudio Rabacchi, Federico Bigazzi, Mariarita Puntoni, et al.
Journal of Clinical Apheresis|October 19, 2023
Comorbidity in lipoprotein apheresis: Their role in the era of new lipid-lowering therapiesFrancesco Sbrana, Mascia Pianelli, Roberta Luciani, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|October 3, 2009
Low high-density lipoprotein predicts death in patients with mild left ventricular dysfunction regardless of coronary atherosclerosisTiziana Sampietro, Federico Bigazzi, Mariarita Puntoni, et al.
Hormones (Athens, Greece)|November 24, 2023
PCSK9 and leptin plasma levels in anorexia nervosaFederico Bigazzi, Carlotta Francesca De Pasquale, Sandra Maestro, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|September 29, 2023
Major cardiovascular events increase in long-term proprotein convertase subtilisin/kexin type 9 inhibitors therapy: the Tuscany cost-effective studyFrancesco Sbrana, Beatrice Dal Pino, Federico Bigazzi, et al.
Biochemical and Biophysical Research Communications|April 1, 2014
Early senescence in heterozygous ABCA1 mutation skin fibroblasts: a gene dosage effect beyond HDL deficiency?Mariarita Puntoni, Federico Bigazzi, Laura Sabatino, et al.
Pageof 4